Biocept to Present at the LD Micro Main Event XV
19 October 2022 - 11:00PM
Business Wire
Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular
diagnostic assays, products and services, announces that management
will present at the LD Micro Main Event XV on Wednesday, October 26
at 2:30 p.m. Pacific time (5:30 p.m. Eastern time). The conference
is being held at the Luxe Sunset Boulevard Hotel in Los
Angeles.
A webcast of the presentation will be live and archived on the
Events and Presentation section of the company website.
About Biocept
Biocept, Inc. develops and commercializes molecular diagnostic
assays that provide physicians with clinically actionable
information for treating and monitoring patients diagnosed with a
variety of cancers. Biocept focuses on cancers that have
metastasized into the central nervous system and has developed its
proprietary CNSide™ cerebrospinal fluid assay that detects
metastatic cancer and quantitatively analyzes cerebrospinal fluid
tumor cells for tumor-associated molecular markers, using
technology first developed for use in blood. Biocept also is
leveraging its molecular diagnostic capabilities to offer
nationwide COVID-19 RT-PCR testing to support public health efforts
during this unprecedented pandemic. For more information, visit
www.biocept.com. Follow Biocept on Facebook, LinkedIn and
Twitter.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221019005017/en/
Investor and Media Contact
LHA Investor Relations Jody Cain Jcain@lhai.com, (310)
691-7100
Biocept (NASDAQ:BIOC)
Historical Stock Chart
From Apr 2024 to May 2024
Biocept (NASDAQ:BIOC)
Historical Stock Chart
From May 2023 to May 2024